Literature DB >> 15934073

The involvement of V(alpha)14 natural killer T cells in the pathogenesis of arthritis in murine models.

Asako Chiba1, Shinjiro Kaieda, Shinji Oki, Takashi Yamamura, Sachiko Miyake.   

Abstract

OBJECTIVE: To examine the physiologic role of natural killer T (NKT) cells bearing V(alpha)14 T cell receptor (TCR) in the pathogenesis of collagen-induced arthritis (CIA) and antibody-induced arthritis in mice.
METHODS: NKT cells were stained with alpha-galactosylceramide-loaded CD1 dimer, and then assessed using flow cytometry. CIA was induced in mice by immunization on days 0 and 21 with type II collagen (CII) emulsified with an equal volume of Freund's complete adjuvant. Anti-CII antibodies were measured by enzyme-linked immunosorbent assay. For antibody-induced arthritis, mice were injected with anti-CII monoclonal antibodies (mAb) followed by lipopolysaccharide, or with serum from KRN TCR-transgenic mice crossed with nonobese diabetic mice (K/BxN). The severity of arthritis was monitored with a macroscopic scoring system.
RESULTS: The number of NKT cells increased in the liver at the peak of the clinical course of CIA. Administration of anti-CD1 mAb inhibited development of CIA. The severity of CIA in NKT cell-deficient mice was reduced compared with that in wild-type mice. The IgG1:IgG2a ratio of anti-CII was elevated and production of interleukin-10 from draining lymph node cells was increased in NKT cell-deficient mice. NKT cell-deficient mice were significantly less susceptible to antibody-induced arthritis.
CONCLUSION: NKT cells contribute to the pathogenesis of arthritis by enhancing autoantibody-mediated inflammation. NKT cells also contribute to the disease process in a deleterious way, due, at least in part, to the alteration of the Th1/Th2 balance in T cell response to CII.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15934073     DOI: 10.1002/art.21056

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  25 in total

1.  TGF-beta-treated antigen presenting cells suppress collagen- induced arthritis through the promotion of Th2 responses.

Authors:  Sundo Jung; Yoon-Kyung Park; Hyunji Lee; Jung Hoon Shin; Gap Ryol Lee; Se-Ho Park
Journal:  Exp Mol Med       Date:  2010-03-31       Impact factor: 8.718

2.  Brief treatment with iNKT cell ligand α-galactosylceramide confers a long-term protection against lupus.

Authors:  Jun-Qi Yang; Peter J Kim; Ram Raj Singh
Journal:  J Clin Immunol       Date:  2011-10-15       Impact factor: 8.317

3.  Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1- NKT cell population.

Authors:  Jonathan M Coquet; Sumone Chakravarti; Konstantinos Kyparissoudis; Finlay W McNab; Lauren A Pitt; Brent S McKenzie; Stuart P Berzins; Mark J Smyth; Dale I Godfrey
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-06       Impact factor: 11.205

4.  Early activation of invariant natural killer T cells in a rheumatoid arthritis model and application to disease treatment.

Authors:  Aurore Miellot-Gafsou; Jérôme Biton; Elvire Bourgeois; André Herbelin; Marie-Christophe Boissier; Natacha Bessis
Journal:  Immunology       Date:  2010-01-27       Impact factor: 7.397

5.  The requirement of natural killer T-cells in tolerogenic APCs-mediated suppression of collagen-induced arthritis.

Authors:  Sundo Jung; Yoon-Kyung Park; Jung Hoon Shin; Hyunji Lee; Soo-Young Kim; Gap Ryol Lee; Se-Ho Park
Journal:  Exp Mol Med       Date:  2010-08-31       Impact factor: 8.718

Review 6.  The split personality of NKT cells in malignancy, autoimmune and allergic disorders.

Authors:  Jeff J Subleski; Qun Jiang; Jonathan M Weiss; Robert H Wiltrout
Journal:  Immunotherapy       Date:  2011-10       Impact factor: 4.196

7.  Activation of natural killer T cells by α-carba-GalCer (RCAI-56), a novel synthetic glycolipid ligand, suppresses murine collagen-induced arthritis.

Authors:  Y Yoshiga; D Goto; S Segawa; M Horikoshi; T Hayashi; I Matsumoto; S Ito; M Taniguchi; T Sumida
Journal:  Clin Exp Immunol       Date:  2011-03-10       Impact factor: 4.330

Review 8.  Invariant natural killer T cells in rheumatic disease: a joint dilemma.

Authors:  Michael B Drennan; Sandrine Aspeslagh; Dirk Elewaut
Journal:  Nat Rev Rheumatol       Date:  2010-02       Impact factor: 20.543

9.  Contrasting roles for Valpha14+ natural killer T cells in a viral model for multiple sclerosis.

Authors:  Ikuo Tsunoda; Tomoko Tanaka; Masaru Taniguchi; Robert S Fujinami
Journal:  J Neurovirol       Date:  2008-12-27       Impact factor: 2.643

Review 10.  Therapeutic manipulation of natural killer (NK) T cells in autoimmunity: are we close to reality?

Authors:  Y Simoni; J Diana; L Ghazarian; L Beaudoin; A Lehuen
Journal:  Clin Exp Immunol       Date:  2013-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.